Brady Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy

59

BRC
Brady

Last Price:

65.73

Seasonality Move:

0.16%

Sell

43

RARE
Ultragenyx Pharmaceutical

Last Price:

39.85

Seasonality Move:

-0.9%

Buy

59

Brady (BRC) is a Buy

Is Brady a Buy, Sell or Hold?

The current Brady [BRC] share price is $65.90. The Score for BRC is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
BRC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

43

Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BRC Stock Price Chart

What is Brady's stock price today?

The Brady share price today is $65.90
The current trend is moderately bearish and BRC is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

The Ultragenyx Pharmaceutical share price today is $39.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

BRC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.76	Buy
Relative Strength Index (14 RSI):	53.99	Buy
Chaikin Money Flow:	-11011	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(64.33 - 68.17)	Sell
Bollinger Bands (100):	(57.85 - 64.51)	Buy

RARE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.7	Sell
Relative Strength Index (14 RSI):	46.74	Sell
Chaikin Money Flow:	84619	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(38.82 - 42.02)	Sell
Bollinger Bands (100):	(40.86 - 48.8)	Sell

BRC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	66.03	Sell
20-day SMA:	66.61	Sell
50-day SMA:	63.01	Buy
200-day SMA:	58.74	Buy
8-day EMA:	66.16	Sell
20-day EMA:	65.78	Buy
50-day EMA:	63.84	Buy
200-day EMA:	59.09	Buy

RARE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	39.53	Buy
20-day SMA:	40.36	Sell
50-day SMA:	41.57	Sell
200-day SMA:	42.46	Sell
8-day EMA:	39.71	Buy
20-day EMA:	40.38	Sell
50-day EMA:	41.84	Sell
200-day EMA:	43.38	Sell

Brady Earnings Growth & BRC Earnings Dates

Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.09 per share, an increase this year of $0.60 per share, and an increase next year of $0.29 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Brady Technical Analysis

	Jun 11	Jun 12	Jun 13	Jun 14	Jun 17	Jun 18	Jun 20	Jun 21	Jun 24	Jun 25
	Jun
	11	12	13	14	17	18	20	21	24	25
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

	Jun 11	Jun 12	Jun 13	Jun 14	Jun 17	Jun 18	Jun 20	Jun 21	Jun 24	Jun 25
	Jun
	11	12	13	14	17	18	20	21	24	25
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):